Roth CH Acquisition Co. Unit
USCTU
USCTU was delisted on the 24th of April, 2024.
7 hedge funds and large institutions have $13.3M invested in Roth CH Acquisition Co. Unit in 2022 Q3 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 6 closing their positions.
46% less funds holding
Funds holding: 13 → 7 (-6)
71% less capital invested
Capital invested by funds: $45.6M → $13.3M (-$32.3M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 6
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Atalaya Capital Management
New York
|
-$19.2M |
| 2 |
CCA
Castle Creek Arbitrage
Avon,
Colorado
|
-$9.03M |
| 3 |
Calamos Advisors
Naperville,
Illinois
|
-$3.04M |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$1.21M |
| 5 |
CS
Clear Street
New York
|
-$6K |
USCTU Hedge Fund Activity: Q3 2022 in Review
7 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Roth CH Acquisition Co. Unit (USCTU) for Q3 2022, worth a combined $13.3M — down 71% from $45.6M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of USCTU and 0 opened new positions — a net loss of 6 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was Atalaya Capital Management, exiting entirely with an estimated $19.2M sold.
- 7 institutional investors held Roth CH Acquisition Co. Unit (USCTU) as of Q3 2022, down from 13 in Q2 2022.
- Funds reported $13.3M of Roth CH Acquisition Co. Unit stock for Q3 2022, down 71% quarter-over-quarter.
- 0 funds opened new Roth CH Acquisition Co. Unit positions in Q3 2022 and 6 closed out, a net change of -6 holders.
- The largest Roth CH Acquisition Co. Unit seller in Q3 2022 was Atalaya Capital Management, an estimated $19.2M sold.
Based on aggregated 13F filings for Q3 2022.